| Date | Title | Description | Source |
| 12.03.2024 | Nvidia стала делать ставку на все технологии, связанные с ИИ... | Последний год для производителя чипов Nvidia стал поворотным, поскольку он превзошел все ожидания и ... | incrussia.... |
| 11.03.2024 | It's not just chips. Nvidia is betting on other tech that co... | Tech It's not just chips. Nvidia is betting on other tech that could be impacted by AI.
Lloyd Lee
20... | businessin... |
| 04.03.2024 | NVIDIA Surpasses Saudi Aramco to Become World's 3rd Richest ... | Inno Flores, Tech Times 04 March 2024, 11:03 pm
NVIDIA, the AI chipmaker, continues its meteoric ris... | techtimes.... |
| 29.04.2021 | Recursion Pharmaceuticals Jumps in Debut After $436 Million ... | First investment made by our partners during their tenure at Mubadala Ventures; Recursion Pharmaceut... | transform.... |
| 06.10.2020 | Catalio Capital Management closes $100M venture fund | Catalio Capital Management, a Baltimore-based investment firm focused on biomedical technology compa... | technical.... |
| 10.09.2020 | Recursion Raises $239M in Series D Equity Financing | Recursion, a Salt Lake City, UT-based digital biology company industrializing drug discovery, raised... | finsmes.co... |
| 10.09.2020 | Recursion raises $239M in Series D funding to revolutionize ... | Recursion, a Salt Lake City-based biotech startup using artificial intelligence technology for drug ... | techstartu... |
| 10.09.2020 | Recursion raises $239M in Series D, partners with lead inves... | “We have made significant progress since our last financing a year ago, doubling the number of clini... | medcitynew... |
| 09.09.2020 | Recursion Pharma nets $239M, plus an AI research contract wi... | Recursion Pharmaceuticals has secured $239 million in new venture capital financing, plus a long-ter... | fiercebiot... |
| 09.09.2020 | Recursion Pharma nets $239M, plus an AI research contract wi... | Recursion Pharmaceuticals has secured $239 million in new venture capital financing, plus a long-ter... | fiercebiot... |
| 08.05.2020 | Ex-AstraZeneca exec Kristen Buck hops aboard Icon as CMO;... | Kristen Buck
→ Prominent CRO player Icon is bolstering its leadership, with Kristen Buck tak... | endpts.com... |
| 11.11.2019 | Investors just poured more than $1 billion into startups usi... | Dr. Ali Parsa, the CEO of Babylon Health. Jack Lewis Williams for Tailor Made London This story is a... | businessin... |
| 27.09.2019 | How To Spot A Synthetic Biology Unicorn | Biotech is projected to reach $775 billion by 2024, but dozens of companies in the field of ... [+] ... | forbes.com... |
| 23.08.2019 | Ignyta founder boosts team at his new cancer startup; Cy... | Jonathan Lim Erasca
→ Ignyta founder and ex-CEO Jonathan Lim is beefing up the team at Erasca, h... | endpts.com... |
| 16.07.2019 | Recursion Pharmaceuticals Raises $121M in Series C Financing | Recursion Pharmaceuticals, a Salt Lake City, UT-based next-gen biopharma company combining automated... | finsmes.co... |
| 16.07.2019 | AI drug discovery company Recursion Pharmaceuticals raises $... | Recursion’s technology works by generating millions of cellular images and using AI-based software a... | medcitynew... |
| 15.07.2019 | AI drug prospector Recursion Pharma nets $121M for its clini... | Machine learning-powered drug discoverer Recursion Pharmaceuticals has secured $121 million in new f... | fiercebiot... |
| 15.07.2019 | AI drug prospector Recursion Pharma nets $121M for its clini... | Machine learning-powered drug discoverer Recursion Pharmaceuticals has secured $121 million in new f... | fiercebiot... |
| 05.06.2018 | Recursion Pharmaceuticals Raises $20.5M Credit Facility from... | Recursion Pharmaceuticals, a Salt Lake City-based innovative biotechnology company specializing in a... | finsmes.co... |
| 15.05.2018 | With new $600M fund, CRV expands into bioengineering investm... | In addition to bioengineering, Fund XVII will also invest in enterprise, consumer-centered companies... | medcitynew... |
| 26.03.2018 | This is how AI will shape drug discovery | An oft-quoted statistic is that it takes 12 years and almost $2 billion dollars to bring an average ... | medcitynew... |
| 05.10.2017 | Recursion Pharmaceuticals Raises $60M in Series B Financing | Recursion Pharmaceuticals, a Salt Lake City, CA-based biotechnology company, raised $60m in Series B... | finsmes.co... |
| 03.10.2017 | Term Sheet — Tuesday, October 3 | DIRTY DEALINGS
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see Fr... | fortune.co... |
| 03.10.2017 | Drug discovery startup Recursion raises $60 million in Serie... | Recursion, a drug discovery startup out of Salt Lake City, Utah has announced a $60 million Series B... | techcrunch... |
| 19.07.2017 | The role of AI in the future of health care | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 08.02.2017 | Recursion Pharmaceuticals Receives $4M Credit Facility from ... | Recursion Pharmaceuticals, Inc., a Salt Lake City-based pharmaceutical discovery company, received a... | finsmes.co... |
| 22.11.2016 | Recursion Pharmaceuticals Closes Additional $2.15M in Series... | Recursion Pharmaceuticals, a Salt Lake City, UT-based drug discovery company, closed an additional $... | finsmes.co... |
| 22.11.2016 | Term Sheet — Tuesday, November 22 | ET CETERA
A few quick notes on today’s deal bonanza, which we can expect to continue through the end... | fortune.co... |
| 25.10.2016 | Recursion Pharmaceuticals Announces John Pereira, MBA as Chi... | SALT LAKE CITY–(BUSINESS WIRE)–October 25, 2016–
Recursion Pharmaceuticals, an emerging biotech in S... | venturebea... |
| 03.10.2016 | Recursion Pharma Raises $13M in Funding | Recursion Pharmaceuticals, a Salt Lake City, UT-based drug discovery company, raised $12.9m in Serie... | finsmes.co... |
| - | AI drug discovery company Recursion Pharmaceuticals raises $... | Salt Lake City-based biotech Recursion Pharmaceuticals, which is part of the group of companies look... | medcitynew... |
| - | Biotech startup with AlphaGo-type AI approach snags $30M | In the world of artificial intelligence and machine learning, Google Deepmind’s AlphaGo program defe... | medcitynew... |
| - | This is how AI will shape drug discovery | As healthcare venture capitalists, we specialize in technologies that have the potential to transfor... | medcitynew... |
| - | With new $600M fund, CRV expands into bioengineering investm... | Early stage venture capital firm CRV has closed a $600 million fund that accomplishes a couple of fi... | medcitynew... |
| - | The AI-Powered Consumer Startup Revolution is Coming | As artificial intelligence and data science have begun to transform enterprise software, one area wh... | twosigmave... |
| - | Going Remote Pt. III: Supporting the Mental Health of Your T... | As the weeks go by and we continue to shelter in place (or begin to open, depending on where you are... | twosigmave... |
| - | The Path to Precision Medicine | We believe data-driven companies can create the most powerful solutions to our world’s biggest probl... | twosigmave... |
| - | AstraZeneca's coronavirus vaccine hit a snag | Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and h... | businessin... |
| - | Recursion raises $239M in Series D, partners with lead inves... | A startup developing artificial intelligence technology for drug discovery is partnering with a larg... | medcitynew... |
